ATE529131T1 - Impfung mittels gezielter transkutaner freisetzung - Google Patents

Impfung mittels gezielter transkutaner freisetzung

Info

Publication number
ATE529131T1
ATE529131T1 AT06795406T AT06795406T ATE529131T1 AT E529131 T1 ATE529131 T1 AT E529131T1 AT 06795406 T AT06795406 T AT 06795406T AT 06795406 T AT06795406 T AT 06795406T AT E529131 T1 ATE529131 T1 AT E529131T1
Authority
AT
Austria
Prior art keywords
vaccination
transcutane
targeted
release
antigen
Prior art date
Application number
AT06795406T
Other languages
English (en)
Inventor
Behazine Combadiere
Annika Vogt
Ulrike Blume-Peytavi
Brigitte Autran
Christine Katlama
Hans Schaeffer
Original Assignee
Fond Bettencourt Schueller
Univ Paris Curie
Univ Charite Universitaetsmedizin Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Bettencourt Schueller, Univ Paris Curie, Univ Charite Universitaetsmedizin Berlin filed Critical Fond Bettencourt Schueller
Application granted granted Critical
Publication of ATE529131T1 publication Critical patent/ATE529131T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06795406T 2005-06-23 2006-06-23 Impfung mittels gezielter transkutaner freisetzung ATE529131T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0506412A FR2887457B1 (fr) 2005-06-23 2005-06-23 Vaccination par ciblage transcutane
PCT/IB2006/002417 WO2006136959A1 (en) 2005-06-23 2006-06-23 Vaccination by transcutaneous targeting

Publications (1)

Publication Number Publication Date
ATE529131T1 true ATE529131T1 (de) 2011-11-15

Family

ID=35785884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06795406T ATE529131T1 (de) 2005-06-23 2006-06-23 Impfung mittels gezielter transkutaner freisetzung

Country Status (9)

Country Link
US (1) US8956617B2 (de)
EP (1) EP1898949B1 (de)
JP (1) JP5123849B2 (de)
AT (1) ATE529131T1 (de)
AU (1) AU2006260596B9 (de)
CA (1) CA2612867C (de)
ES (1) ES2378516T3 (de)
FR (1) FR2887457B1 (de)
WO (1) WO2006136959A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082301A1 (en) 2007-12-20 2009-07-02 Telefonaktiebolaget L M Ericsson (Publ) A method and an apparatus for handling multimedia calls
WO2010050913A1 (en) * 2008-10-31 2010-05-06 The Brigham And Women's Hospital, Inc. Vaccination with poxvirus vectors via mechanical epidermal disruption
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
CA3030720A1 (en) 2010-08-27 2012-03-01 The Board Of Trustees Of The Leland Stanford Junior University Microscopy imaging device with advanced imaging properties
DE102011018499A1 (de) 2011-04-23 2012-10-25 Emc Microcollections Gmbh Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut
JP5917626B2 (ja) * 2014-07-28 2016-05-18 トレムアールエックス， インコーポレイテッド 機械的表皮破壊を介したポックスウイルスベクターによるワクチン接種
FR3132146B1 (fr) * 2022-01-27 2025-10-31 Genoskin Modèle humain ex vivo destiné à l’évaluation du potentiel vaccinal d’une composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5910306A (en) 1996-11-14 1999-06-08 The United States Of America As Represented By The Secretary Of The Army Transdermal delivery system for antigen
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
WO2000046147A2 (en) * 1999-02-03 2000-08-10 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
US6436402B1 (en) * 1999-10-15 2002-08-20 Merck & Co., Inc. Process for making human papillomavirus virus-like particles with improved properties
US6358242B1 (en) * 1999-11-12 2002-03-19 Ceramoptec Industries, Inc. Post laser treatment for permanent hair removal
DK1372708T3 (da) * 2001-02-13 2008-10-20 Us Gov Sec Army Vaccine til transkutan immunisering mod rejsediarre
AU2002367977B2 (en) * 2001-08-13 2008-06-19 University Of Rochester Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
US20030190308A1 (en) * 2002-03-19 2003-10-09 Braun Ralph P. Adjuvant
AU2003257007A1 (en) * 2002-08-01 2004-02-23 Immusonic, Inc. Beta-glucan containing composites, methods for manufacturing and for using such composites
EP1449520A1 (de) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Verwendung von PVP-Jod zur Behandlung von Herpes
AU2004224761A1 (en) * 2003-03-26 2004-10-07 Cytos Biotechnology Ag HIV-peptide-carrier-conjugates
BRPI0415466A (pt) * 2003-10-24 2006-12-19 Alza Corp método e sistema de pré-tratamento para intensificar a distribuição transdérmica de fármacos

Also Published As

Publication number Publication date
AU2006260596A1 (en) 2006-12-28
WO2006136959A1 (en) 2006-12-28
EP1898949B1 (de) 2011-10-19
US20100285099A1 (en) 2010-11-11
FR2887457A1 (fr) 2006-12-29
JP2008543924A (ja) 2008-12-04
ES2378516T3 (es) 2012-04-13
AU2006260596B2 (en) 2012-05-10
CA2612867A1 (en) 2006-12-28
EP1898949A1 (de) 2008-03-19
JP5123849B2 (ja) 2013-01-23
FR2887457B1 (fr) 2007-10-05
CA2612867C (en) 2015-08-11
AU2006260596B9 (en) 2012-09-13
US8956617B2 (en) 2015-02-17

Similar Documents

Publication Publication Date Title
EA201170493A1 (ru) Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот
CY1121789T1 (el) Νεες ανοσοενισχυτικες συνθεσεις
WO2010060051A3 (en) Systems biology approach predicts the immunogenicity of vaccines
WO2008060669A3 (en) Vaccine for avian influenza and methods of use
MX2018010586A (es) Nanovacuna de activacion de "sting" para inmunoterapia.
ATE426412T1 (de) Adjuvante influenza-vakzine
DK2066344T3 (da) Inaktiveret Poliovirus kombinationsvaccine
MX372965B (es) Formulaciones adyuvadas de vacunas de difteria, tetanos y tos ferina (dtp) de refuerzo.
TW200806316A (en) Yeast-based vaccine for inducing an immune response
EP2061504A4 (de) Kombinationstherapie für krebs und infektionskrankheiten mit anti-b7-h1-antikörpern
ZA200802892B (en) Vaccines and methods to treat canine influenza
CL2009001195A1 (es) Adyuvante inmune que comprende un inhibidor de iap capaz de modular la actividad inmune; composicion farmaceutica y vacuna que lo comprenden; metodo para mejorar una respuesta inmune de un individuo; metodo para tratar un cancer en un individuo; metodo para tratar infeccion; metodo para tratar trastornos autoinmune.
EA201201203A1 (ru) Терпимое и минимально инвазивное устройство электропорации кожи
AR080313A1 (es) Composiciones de virus de moquillo canino (cdv) recombinante y sus usos
EP2525817A4 (de) Impfstoffvektoren und verfahren zur verstärkung von immunreaktionen
EP2274001A4 (de) Impfung mit hitzeschockprotein gp96 und anwendungsverfahren dafür
PE20151588A1 (es) Vacuna contra el virus del dengue
BR0316346A (pt) Vacina para vìrus do nilo ocidental
WO2008148057A3 (en) Cationic lipids compositions and methods for enhancing immune responses to vaccines
IN2015MN00038A (de)
MX381211B (es) Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia.
WO2011159814A3 (en) Novel live recombinant booster vaccine against tuberculosis
EP1869225A4 (de) Metapneumovirenstämme und ihre verwendung in impfstoffformulierungen und als vektoren für die expression antigener sequenzen und verfahren zur ausbreitung des virus
ATE529131T1 (de) Impfung mittels gezielter transkutaner freisetzung
BR112012009239A2 (pt) ''adjuvante para vacinas,vacina, uso do adjuvante, vetores de expressão eucariótica e células eucarióticas modificadas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1898949

Country of ref document: EP